Analyst Price Targets — EVH
| Date | Analyst | Firm | Target | Price @ Post | Source | Headline |
|---|---|---|---|---|---|---|
| June 30, 2026 9:20 am | — | Truist Financial | $7.00 | $5.77 | TheFly | Evolent Health downgraded to Hold from Buy at Truist |
| May 12, 2026 10:38 am | — | Canaccord Genuity | $6.00 | $3.96 | TheFly | Evolent Health price target raised to $6 from $5 at Canaccord |
| February 25, 2026 6:23 pm | — | Truist Financial | $6.00 | $3.05 | TheFly | Evolent Health price target lowered to $6 from $10 at Truist |
| February 25, 2026 2:20 pm | Sean Dodge | BMO Capital | $3.50 | $3.03 | StreetInsider | Evolent Health (EVH) PT Lowered to $3.50 at BMO Capital |
| February 2, 2026 12:14 pm | David Larsen | BTIG | $10.00 | $3.21 | TheFly | Evolent Health price target lowered to $10 from $16 at BTIG |
| December 2, 2025 3:16 pm | — | Piper Sandler | $6.00 | $3.84 | StreetInsider | Evolent Health (EVH) PT Lowered to $6 at Piper SandlerMember Login |
| January 16, 2025 1:53 am | Kevin Caliendo | UBS | $14.00 | $9.97 | TheFly | Evolent Health price target lowered to $14 from $27 at UBS |
| January 15, 2025 8:59 pm | Jailendra Singh | Truist Financial | $20.00 | $9.97 | TheFly | Evolent dips after Truist warns guidance may be 'significantly' below consensus |
| January 14, 2025 3:36 pm | Sean Dodge | RBC Capital | $17.00 | $11.96 | StreetInsider | Evolent Health (EVH) PT Lowered to $17 at RBC Capital as Membership Declines |
| January 10, 2025 12:14 pm | Constantine Davides | JMP Securities | $18.00 | $12.54 | TheFly | Evolent Health price target lowered to $18 from $27 at JMP Securities |
Latest News for EVH
Healthcare IT is emerging as AI's next growth story as providers adopt AI to cut costs & improve care. Here we present three stocks that are likely to benefit.
WASHINGTON, July 8, 2026 /PRNewswire/ -- Evolent Health, Inc. (NYSE: EVH), a company focused on achieving better health outcomes for people with complex conditions, today announced it will release its second quarter 2026 financial results on Thursday, August 6, 2026, before market open, with a conference call to follow at 8 a.m. ET. Shareholders and interested participants may listen to a live broadcast of the…
Evolent Health, Inc (EVH) is looking like an interesting pick from a technical perspective, as the company reached a key level of support. Recently, EVH's 50-day simple moving average crossed above its 200-day simple moving average, known as a "golden cross.
Evolent Health (EVH) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock suggests that there could be more strength down the road.
Healthcare payrolls keep climbing, and hospital systems, payers, and clinics are now openly treating agentic AI as the cheapest unit of labor on the market.
🧮 Earnings Move Analyzer
Insider Trading
Insider Trading
| Name | Role | Date | Type | Shares | Price | Form | Link |
|---|
Senate Trading
No Senate trades found for EVH.
U.S. House Trading
House Trades Disclosures
| Name | Transaction Date | Type | Asset | Amount | Link |
|---|
Options Chain
Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.